Rib Ewing Sarcomas in Children and Young Adults: A Large National Retrospective Series

Le résumé fourni par la source

BACKGROUND AND PURPOSE: Ewing sarcoma (ES) is the most prevalent malignant thoracic tumor in childhood and young adults. This study reports the outcome of a national cohort treated in an international prospective trial for a localized rib ES, with a long follow-up. MATERIAL AND METHODS: All the patients treated in a prospective trial (December 1999-April 2013) were included. Data were collected from a prospective database and supplemented by a retrospective review of the patients' files. Local control alone rate, progression-free survival (PFS), and overall survival (OS) were assessed. Multivariate analyses were conducted to adjust for classical prognosis factors. RESULTS: Eighty-two patients, median age 13.6 years, were included. All received induction chemotherapy. Surgery was completed (R0) in 88%. Overall, 66% had good histological response (GR). Radiotherapy (RT) was performed on the primary tumor in 28%, on the hemithorax in 13%, or on both in 32%. With a median follow-up of 12 years, 28 patients (34%) relapsed. Five-year local control rate was 95% (95%CI [89%-95%]), 5-year PFS was 73% (95%CI [62%-81%]), and 5-year OS was 79% (95%CI [69%-87%]). In multivariate analysis, pleural effusion was significantly associated with poor PFS (p = 0.049). In the case of R0 and GR (n = 41), no significant difference in PFS/OS (p = 0.16/p = 0.36) was reported according to adjuvant local RT. Overall, 38% of scoliosis and 7.3% of secondary cancer were reported. CONCLUSION: A multidisciplinary approach in high-risk patients can provide good local control in rib ES. In patients who have undergone R0 surgery and are GR, omitting adjuvant RT of the surgical bed may be discussed.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.